Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

This announcement is in response to the growing need in the industry for solutions like elluminate CTMS that can automate operational data pipelines and reduce the time spent on manual data tracking processes to accelerate clinical development. ​ ​

Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

Feb 15, 2021, 12:30 PM by

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

Feb 15, 2021, 12:30 PM by

Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN

Feb 15, 2021, 12:30 PM by

Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.

Feb 15, 2021, 12:30 PM by

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Feb 12, 2021, 01:00 AM by User Not Found

Bio-IT World | New machine learning framework estimates asymptomatic cases, helium microscope used to visualize SARS CoV-2, SARS CoV-2 mutations develop in single patient, and new vaccine platforms. Plus: clinicians at UCI Health develop successful system for monoclonal antibody delivery, New Yorkers are responding more favorably to the new COVID-19 vaccine, and old drugs may be repurposed as COVID-19 treatments.

Feb 11, 2021, 01:00 AM by User Not Found

Bio-IT World | Messenger RNA (mRNA) vaccines were the focus of a symposium on COVID-19 vaccines held during last week’s COVID-19 and Cancer virtual meeting of the American Association for Cancer Research. To date, only two vaccines have received Emergency Use Authorization by the U.S. Food and Drug Administration and both are mRNA vaccines—one developed by Moderna and the other by Pfizer and BioNTech.

Feb 10, 2021, 18:53 PM by User Not Found

Bio-IT World | Sema4 announced its planned merger with CM Life Sciences today. The transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP. The transaction is expected to provide up to $793 million in immediate cash proceeds.

Feb 10, 2021, 01:00 AM by User Not Found

Bio-IT World | The impact of the COVID-19 pandemic on our nation’s blood supply was not very apparent in public discussion. And yet the radical shifts in the demand for blood products, and the availability thereof, should be studied and analyzed to improve the robustness and resilience of our blood supply.

Feb 9, 2021, 01:00 AM by User Not Found

Bio-IT World | The computational biology team at St. Jude has published the latest on GenomePaint, one of the visualization features in the St. Jude Cloud platform, in the January issue of Cancer Cell.

Feb 5, 2021, 01:00 AM by User Not Found

Bio-IT World | Genetic sequence deletions help SARS-CoV-2 escape antibodies, molecular behavior of COVID-19 drugs, and the latest COVID-19 forecasts include two new variants. Plus: N439K variant shows two-fold increase in binding affinity and heparin inhibits SARS-CoV-2 spike protein, could be repurposed.

Feb 4, 2021, 01:00 AM by User Not Found

Bio-IT World | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing.

Feb 3, 2021, 01:00 AM by User Not Found

Bio-IT World | Popular opinion is that two big shifts have changed the game for bioinformatics. The first is single cell ‘omics, the other is a more recent move to a new model of drug discovery that looks to leverage the vast amounts of human genetic data now being generated in support of precision medicine. But to achieve datasets with the 100,000s of patients and treatment conditions that are needed for statistical power in pharma R&D and precision medicine, IT tools to manage billions of cells are essential.

Feb 2, 2021, 18:31 PM by User Not Found

Bio-IT World | Intel and Google have joined the National Institutes of Health (NIH) All of Us Research Program in its historic effort to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench.

Feb 2, 2021, 01:00 AM by User Not Found

Bio-IT World | Only a fraction of the genetic diversity among African individuals had previously been surveyed—even by large-scale efforts such as the 1000 Genomes Project. That’s why H3Africa’s sequencing is so important. A study published last year in Nature found evidence for natural selection in and around 62 previously unreported genes.

Jan 29, 2021, 14:22 PM by User Not Found

Bio-IT World | Bio-IT World is accepting entries for the 2021 Innovative Practices Awards competition. The deadline for entry is March 19, 2021, and the $300 application fee will be waived for entrants who meet the early deadline of February 19, 2021.

Jan 29, 2021, 13:35 PM by

MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA),” which launched on December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.